| 000 | 01904 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515015000.0 | ||
| 264 | 0 | _c20060504 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a0002-9262 | ||
| 024 | 7 |
_a10.1093/aje/kwj079 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrentice, Ross L | |
| 245 | 0 | 0 |
_aCombined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. _h[electronic resource] |
| 260 |
_bAmerican journal of epidemiology _cApr 2006 |
||
| 300 |
_a589-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBias |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aObservation |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aProgestins _xadministration & dosage |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aWomen's Health |
| 700 | 1 | _aLanger, Robert D | |
| 700 | 1 | _aStefanick, Marcia L | |
| 700 | 1 | _aHoward, Barbara V | |
| 700 | 1 | _aPettinger, Mary | |
| 700 | 1 | _aAnderson, Garnet L | |
| 700 | 1 | _aBarad, David | |
| 700 | 1 | _aCurb, J David | |
| 700 | 1 | _aKotchen, Jane | |
| 700 | 1 | _aKuller, Lewis | |
| 700 | 1 | _aLimacher, Marian | |
| 700 | 1 | _aWactawski-Wende, Jean | |
| 773 | 0 |
_tAmerican journal of epidemiology _gvol. 163 _gno. 7 _gp. 589-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/aje/kwj079 _zAvailable from publisher's website |
| 999 |
_c16096025 _d16096025 |
||